You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新鋭醫藥(06108.HK)擬6800萬元出售維健國際8.11%股權
格隆匯 04-20 21:21

格隆匯4月20日丨新鋭醫藥(06108.HK)公佈,於2021年4月20日,賣方Major Bright Holdings Limited(公司全資附屬公司)及買方維健國際有限公司訂立股份購回協議,據此,賣方有條件同意出售,而買方有條件同意購買待售股份,代價為人民幣6800萬元。於股份購回協議日期,待售股份佔目標公司維健國際有限公司已發行股本約8.11%。

目標集團主要從事於中國分銷藥劑製品及透過持有多種進口處方藥物於中國的分銷權建立廣泛的分銷網絡。緊隨完成後,集團將不再於目標集團各成員公司中持有任何股權。

公司表示,集團於目標集團的投資乃分類為按公平值計入其他全面收益列賬的股本工具及其財務表現並無綜合入賬至集團財務報表,故被視為集團的非核心資產。由於集團於目標集團持有少數權益而並無控制權或重大影響力,目標集團的業務營運與集團的業務營運明確區分。集團一直為目標集團的被動投資者,從未參與目標集團的日常管理或營運。出售事項貫徹集團出售或縮減其非核心業務及資產和將資源重新集中投放於其核心業務的持續政策。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account